Spots Global Cancer Trial Database for locally advanced gastric adenocarcinoma
Every month we try and update this database with for locally advanced gastric adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma | NCT05507658 | Locally Advance... | Tislelizumab co... | 18 Years - 80 Years | Xijing Hospital | |
| Tislelizumab Combined With XELOX as Neoadjuvant Therapy for G/GEJ Adenocarcinoma | NCT05507658 | Locally Advance... | Tislelizumab co... | 18 Years - 80 Years | Xijing Hospital | |
| Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors | NCT04007744 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Metastatic Gast... Metastatic Gast... Metastatic Head... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Urot... Recurrent Head ... Refractory Lung... Stage IV Cutane... Stage IV Lung C... Unresectable Ma... Unresectable Me... | Pembrolizumab Sonidegib | 18 Years - | Mayo Clinic | |
| Oxaliplatin Plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma | NCT01880632 | Gastric Adenoca... | XELOX | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
| Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma | NCT05508399 | Locally Advance... PD-1 | DNA panel and R... | 18 Years - 80 Years | Xijing Hospital | |
| Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma | NCT05508399 | Locally Advance... PD-1 | DNA panel and R... | 18 Years - 80 Years | Xijing Hospital | |
| Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | NCT04908566 | Locally Advance... | PD-1 antibody c... PD-1 antibody c... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Study of Comparing of With and Without Sequential Therapy of S-1 | NCT05813015 | Locally Advance... Chemotherapy Ef... | Docetaxel Tegafur-Gimerac... | 18 Years - 75 Years | Zhejiang University | |
| Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors | NCT04007744 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Locally Advance... Locally Advance... Locally Advance... Metastatic Gast... Metastatic Gast... Metastatic Head... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Urot... Recurrent Head ... Refractory Lung... Stage IV Cutane... Stage IV Lung C... Unresectable Ma... Unresectable Me... | Pembrolizumab Sonidegib | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
